Edition:
United States

Sellas Life Sciences Group Inc (SLS.OQ)

SLS.OQ on NASDAQ Stock Exchange Capital Market

0.16USD
16 Aug 2019
Change (% chg)

$0.00 (+1.21%)
Prev Close
$0.16
Open
$0.16
Day's High
$0.16
Day's Low
$0.15
Volume
3,544,030
Avg. Vol
3,488,467
52-wk High
$2.46
52-wk Low
$0.10

Latest Key Developments (Source: Significant Developments)

Sellas Life Sciences Reports Q2 Loss Per Share $0.13
Wednesday, 14 Aug 2019 04:15pm EDT 

Aug 14 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES PROVIDES BUSINESS UPDATE AND REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.13.AS OF JUNE 30, 2019, CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $12.8 MILLION.  Full Article

Sellas Advances Galinpepimut-S In Combination With Keytruda Program
Wednesday, 31 Jul 2019 08:15am EDT 

July 31 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS ADVANCES GALINPEPIMUT-S (GPS) IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) PROGRAM WITH DOSING OF FIRST PATIENT IN PHASE 1/2 BASKET STUDY.SELLAS LIFE SCIENCES GROUP INC - FIRST CLINICAL DATA EXPECTED IN Q1 OF 2020.SELLAS LIFE SCIENCES GROUP INC - STUDY IS BEING CONDUCTED WITH MERCK UNDER A CLINICAL TRIAL COLLABORATION AND SUPPLY AGREEMENT.SELLAS LIFE SCIENCES GROUP INC - TRIAL TO ENROLL PATIENTS WITH OVARIAN, COLORECTAL, TRIPLE NEGATIVE BREAST, AND SMALL CELL LUNG CANCERS.  Full Article

Sellas Life Sciences Announces Pricing Of $15 Million Public Offering
Friday, 14 Jun 2019 08:30am EDT 

June 14 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES ANNOUNCES PRICING OF $15 MILLION PUBLIC OFFERING.SELLAS LIFE SCIENCES GROUP INC - SHARES OF COMMON STOCK AND ACCOMPANYING COMMON WARRANTS AT A COMBINED PUBLIC OFFERING PRICE OF $0.15 PER SHARE..SELLAS LIFE SCIENCES GROUP INC - COMMON WARRANTS WILL HAVE AN EXERCISE PRICE OF $0.50 PER SHARE.SELLAS LIFE SCIENCES GROUP INC - OFFERING 26.4 MILLION SHARES TOGETHER WITH COMMON STOCK WARRANTS.  Full Article

Sellas Life Sciences Group Files For Offering Of 33.9 Mln Shares And Warrants To Buy Up To 33.9 Mln Shares
Thursday, 6 Jun 2019 06:32pm EDT 

June 6 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES GROUP FILES FOR OFFERING OF 33.9 MILLION COMMON SHARES AND WARRANTS TO PURCHASE UP TO 33.9 MILLION COMMON SHARES - SEC FILING.  Full Article

Sellas Life Sciences Group Gets Notification From Nasdaq Stock Market
Friday, 31 May 2019 05:18pm EDT 

May 31 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES GROUP INC - GOT NOTIFICATION FROM NASDAQ STOCK MARKET LLC INDICATING THAT CO WAS NOT IN COMPLIANCE WITH NASDAQ LISTING RULE.  Full Article

Sellas Life Sciences Group Files For Offering Of Common Stock And Pre-Funded Warrants To Buy Shares Of Common Stock Of Up To $23.0 Mln
Thursday, 23 May 2019 06:17pm EDT 

May 23 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES GROUP FILES FOR OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS TO BUY SHARES OF COMMON STOCK OF UP TO $23.0 MILLION - SEC FILING.  Full Article

Sellas Life Sciences Q1 Loss Per Share $0.22
Wednesday, 15 May 2019 04:30pm EDT 

May 15 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES PROVIDES BUSINESS UPDATE AND REPORTS FIRST QUARTER 2019 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.22.AS OF MARCH 31, 2019, CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $2.6 MILLION.AS OF MARCH 31, 2019, CASH AND CASH EQUIVALENTS TOTALED APPROXIMATELY $2.6 MILLION..  Full Article

Sellas Life Sciences Q3 Loss Per Share $0.53
Thursday, 15 Nov 2018 07:30am EST 

Nov 15 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES PROVIDES BUSINESS UPDATE AND REPORTS THIRD QUARTER 2018 FINANCIAL RESULTS.Q3 LOSS PER SHARE $0.53.QTRLY EARNINGS PER SHARE $0.53.SELLAS LIFE SCIENCES GROUP - AS OF SEPT 30, 2018, UNRESTRICTED CASH AND CASH EQUIVALENTS TOTALED $10.0 MILLION.  Full Article

Sellas Life Sciences Announces Settlement Of Counterclaims Against JGB
Friday, 9 Nov 2018 08:30am EST 

Nov 9 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES ANNOUNCES SETTLEMENT OF COUNTERCLAIMS AGAINST JGB (CAYMAN) NEWTON, LTD. FOR $6.6 MILLION PAYMENT BY JGB.SELLAS LIFE SCIENCES GROUP INC - DEBENTURE AND ALL SECURITY INTERESTS HELD BY JGB TERMINATED.SELLAS LIFE SCIENCES - JGB HAS PAID CO ABOUT $6.6 MILLION IN EXCHANGE FOR DISCHARGE OF CLAIMS & COUNTERCLAIMS ASSERTED BY CO & JGB IN LITIGATION.  Full Article

Sellas Life Sciences Files For Offering Of Up To $30 Mln
Wednesday, 23 May 2018 04:26pm EDT 

May 23 (Reuters) - Sellas Life Sciences Group Inc ::SELLAS LIFE SCIENCES GROUP INC FILES FOR OFFERING OF UP TO $30 MILLION - SEC FILING.  Full Article